Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-040168
Filing Date
2011-07-12
Accepted
2011-07-12 16:27:06
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v228271_10k.htm 10-K 748467
2 v228271_ex31-1.htm EX-31.1 14591
3 v228271_ex31-2.htm EX-31.2 15480
4 v228271_ex32-1.htm EX-32.1 6644
5 v228271_ex32-2.htm EX-32.2 7090
6 v228271_ex99-1.htm EX-99.1 36277
7 v228271_ex99-2.htm EX-99.2 18238
8 v228271_ex99-3.htm EX-99.3 21776
9 v228271_ex99-4.htm EX-99.4 24289
10 v228271_ex99-5.htm EX-99.5 26808
11 v228271_ex99-6.htm EX-99.6 29400
12 v228271_ex99-7.htm EX-99.7 32422
  Complete submission text file 0001144204-11-040168.txt   982752
Mailing Address 2808 COWAN CIRCLE LAS VEGAS NV 89107
Business Address 2808 COWAN CIRCLE LAS VEGAS NV 89107 866-446-1869
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53231 | Film No.: 11964165
SIC: 1311 Crude Petroleum & Natural Gas